Tirzepatide (Zepbound, Mounjaro) A 2022 clinical trial of people with obesity or overweight found that a once-weekly tirzepatide injection produced an average weight loss of 15%21% in 72 weeks (a bit less than a year and a half)
The findings based on a survey conducted from May to December 2022 also indicate, however, that these executives and consultants want more data on the drugs additional health benefits to warrant the high cost before offering coverage to their employees
FitRx also offers semaglutide, the active ingredient in Ozempic & Wegovy, and other compounded GLP-1 medications, at an affordable out-of-pocket price
You stop losing weight despite following your semaglutide diet plan consistently
Additionally, the animal model utilized in our study represents a chronic heroin dependence model, and its relevance to heroin addiction requires further investigation